TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog

Newest cap analog product improves mRNA potency with greater protein expression, offers time and cost savings, and streamlines manufacturing to drive critical therapeutic and vaccine development

Verana Health Research on Missing Data for Diabetic Retinopathy Severity Published in the Journal of the American Medical Informatics Association

Verana Health Research on Missing Data for Diabetic Retinopathy Severity Published in the Journal of the American Medical Informatics Association

BRIM plans to launch a new funding round to accelerate late-stage clinical trial and initiate a new phase 2 trial for orphan drug BRM424 in the U.S

BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) announced today that the Board of Directors has approved a seasoned equity offering that will issue 20 to 22.5 million shares of new stocks priced at 60-80 New Taiwan Dollars (~USD 2-2.67) per share.

The Growing Demand for Disposable Plastic Blood Bags: An Overview of the Market

Sinequa Helps Accelerate Drug Development and Clinical Research with AI-Powered Scientific Search

Sinequa presents generative AI and neural search capabilities for accelerating clinical research and drug development at Bio-IT World 2023

Tesis Biosciences Announces New Test That Can Identify Those in Most Danger from Covid-19

Tesis Biosciences, the leader in targeted genetic sequencing, has developed a new test that identifies the genetic mutations that puts people in the greatest danger from the Covid-19 virus.

Form Bio Announces FORMsightAI, a Breakthrough AI Solution Set for Predicting and Optimizing Cell & Gene Therapy Manufacturability

New Offering Enables Therapy Developers and CDMOs to Simulate Bioreactor Runs and Optimize Therapeutic Constructs for Yield and Safety

ZeOmega Named a Top Performer in KLAS “Payer Care Management 2023” Report

Company’s Clients Report the Highest Satisfaction, Extol Jiva Population Healthcare Enterprise Management Platform’s Functionality Across Use Cases

Micropep Demonstrates Excellent Field Efficacy for New Micropeptide Active Ingredient

Global field trials of safe and sustainable micropeptides illustrate potential in crop protection applications

CD Formulation Unveils Its Latest Offering: A Comprehensive Line of Pharmaceutical Formulation Characterization Testing Services

UMass Chan Medical School researchers pilot cognitive screening technology for early detection of Alzheimer’s disease

Primary care providers are using AI-enhanced assessments from Linus Health

Alfa Chemistry Expresses Gratitude to Everyone Who Visited Its Booth at the ACS Spring 2023 Conference

Famed as a leading provider of chemicals, analytical services, and engineering solutions, Alfa Chemistry recently expressed gratitude to everyone who visited its booth at the ACS Spring 2023 conference in San Diego, California in the past month.

Huateng Pharma Develops CDK4/6 Inhibitors Against Breast Cancer

Biopharma PEG Supplies PEG Products For Lipid Nanoparticles (LNPs)

Glycobiology: Illuminating the Role of Sugars in Health, Disease, and Beyond

The Rising Prevalence of Infectious Diseases across the Globe Are Driving the Demand within the Glycobiology Market

Kyruus Expands Leadership Team with Addition of New Chief Product Officer Peter Boumenot

Kyruus announced today that Peter Boumenot has joined the company’s executive team as Chief Product Officer.

New Clinical Study Supports the Use of NeuraLight’s Oculometric Platform as a Viable Adjunct Assessment Tool in ALS

Authors of a recently published clinical study found a significant correlation between oculometric data and clinical assessment in ALS patients participating in a Phase IIb clinical drug trial

Onyx Scientific increases non-GMP capabilities with CMC facility expansion

ALMADEN GENOMICS UPDATES G.NOME PLATFORM WITH JUPYTER NOTEBOOK INTEGRATION

Almaden Genomics updated its g.nome platform to integrate with Jupyter Notebook, allowing bioinformaticians and data scientists to leverage the cloud-native platform’s genomic workflows in the environment and programming language they are most familiar with.

Watson-Marlow to demonstrate fluid path product range at INTERPHEX 2023

About Watson-Marlow Fluid Technology Solutions Watson-Marlow Fluid Technology Solutions (WMFTS) is a world leader in manufacturing niche peristaltic pumps and associated fluid path technologies for the life sciences and process industries. WMFTS is a wholly owned subsidiary of Spirax-Sarco Engineering plc and is headquartered in Cornwall, England, with operations in 43 countries. Further information can be found at www.wmfts.com.